Skip to content
Toggle main navigation
PURPOSE logo
PURPOSE logo
  • Home
  • Events
  • Opportunities
  • News & Publications
  • T90/R90 HEAL Pain Cohort Program
  • Mobile App
  • About
  • Exhibit
  • Affiliate Networks
    • Music4Pain (U24)
    • ENSEMBLE Network (U24)
    • Pain Research Forum (PRF)
    • ForceNET (U24)
    • NeuronS_MATTR (U24)
    • SPINEWORK Network (U24)
    Log in
    Request to Join

    News & Publications

    Do you have news or publications to share with the PURPOSE Network? Submit your news below.

    Submit Your News or Publication
    All
    Acquired Cognitive Impairment
    Acupuncture
    Addiction
    Ageing
    Alcohol Use / Alcohol Use Disorder (AUD)
    Analgesics
    Analgesics, Topical
    Anatomy
    Anesthesia, General
    Anesthesia, Intravenous regional
    Anesthesia, Local
    Anesthesia, Spinal
    Animal Models
    Anxiety
    Arthritis, Rheumatoid
    See all

    Highlighted News

    Results (6)

    Effects of perioperative esketamine infusion on chronic pain after video-assisted thoracoscopic lung resection: a multicentre, randomised, double-blind clinical trial

    Effects of perioperative esketamine infusion on chronic pain after video-assisted thoracoscopic lung resection: a multicentre, randomised, double-blind clinical trial

    Br J Anaesth. 2026 Oct 28:S0007-0912(26)00693-8. doi: 10.1016/j.bja.2026.08.039. Online ahead of print.ABSTRACTBACKGROUND: Chronic postsurgical pain after thoracoscopic surgery remains common. We investigated whether perioperative low-dose esketamine infusion would reduce chronic pain after video-assisted thoracoscopic lung resection.METHODS: In this multicentre, randomised controlled trial, 914 a
    October 29, 2026
    Integrating Ketamine and Autogenic Training for Chronic Pain: A Case Study at Walter Reed National Military Medical Center

    Integrating Ketamine and Autogenic Training for Chronic Pain: A Case Study at Walter Reed National Military Medical Center

    Mil Med. 2026 Aug 20:usag396. doi: 10.1093/milmed/usag396. Online ahead of print.ABSTRACTKetamine has demonstrated efficacy in managing chronic pain and, when combined with psychotherapy, alleviating psychiatric symptoms. However, no published studies have examined the integration of ketamine infusion with autogenic training for chronic pain management. This case study evaluated the feasibility of
    August 20, 2026
    N-methyl-d-aspartate receptor subunits interacting with regulators mediate neuropathic pain: from mechanisms to therapy

    N-methyl-d-aspartate receptor subunits interacting with regulators mediate neuropathic pain: from mechanisms to therapy

    Front Neuroendocrinol. 2026 Jun 18:101267. doi: 10.1016/j.yfrne.2026.101267. Online ahead of print.ABSTRACTNMDARs and their interacting proteins drive central sensitization in neuropathic pain, yet their pathological effects are critically shaped by upstream neuroendocrine regulators. This review synthesizes evidence across three dimensions: (i) glucocorticoids amplify pain via spinal glucocortico
    June 19, 2026
    Efficacy of Low-Dose Intravenous Ketamine With Spinal Anesthesia for Postoperative Pain Control in Total Knee Arthroplasty: A Randomized Clinical Trial

    Efficacy of Low-Dose Intravenous Ketamine With Spinal Anesthesia for Postoperative Pain Control in Total Knee Arthroplasty: A Randomized Clinical Trial

    Pain Res Manag. 2026;2026(1):e8176907. doi: 10.1155/prm/8176907.ABSTRACTBACKGROUND: The efficacy of low-dose intravenous (IV) ketamine as an adjunct analgesic to spinal anesthesia in total knee arthroplasty (TKA) remains uncertain. This study aims to assess ketamine's impact on postoperative pain level and opioid consumption.METHODS: In a randomized, triple-blind, placebo-controlled trial conducte
    June 17, 2026
    Retrospective Chart Review Evaluating Efficacy and Tolerability of Ketamine Continuous Infusion for Cancer-Related Pain

    Retrospective Chart Review Evaluating Efficacy and Tolerability of Ketamine Continuous Infusion for Cancer-Related Pain

    Am J Hosp Palliat Care. 2026 May 14:10499091261452628. doi: 10.1177/10499091261452628. Online ahead of print.ABSTRACTContext Ketamine is used to treat refractory cancer pain, but evidence for analgesic and opioid-sparing benefits remains mixed.Objective This study assessed the efficacy and tolerability of ketamine continuous infusion (CI) for cancer pain.Methods This retrospective analysis assesse
    May 14, 2026
    S-ketamine mitigates paclitaxel-induced pain-related anxiety-like behavior through downregulation of mGluR5 and activation of the BDNF/TrkB signaling pathway

    S-ketamine mitigates paclitaxel-induced pain-related anxiety-like behavior through downregulation of mGluR5 and activation of the BDNF/TrkB signaling pathway

    Front Neurol. 2026 Apr 23;17:1801549. doi: 10.3389/fneur.2026.1801549. eCollection 2026.ABSTRACTBACKGROUND: Paclitaxel (PTX), a broad-spectrum anti-tumor drug, is extensively employed as a first-line chemotherapy for solid tumors, including lung and breast cancers. However, it induces chemotherapy-related pain and anxiety in over 53% of patients. S-ketamine, the S-enantiomer of ketamine, exerts ra
    May 12, 2026
    Contact
    Neurovations Education
    [email protected]

    United States

    PURPOSE@PainResearchers.com
    707-260-0848
    Links
    • NIH HEAL Initiative
    • Research in Pain Management